Profile data is unavailable for this security.
About the company
Vaccinex, Inc. is a clinical-stage biotechnology company. The Company is engaged in the discovery and development of targeted biotherapeutics to treat serious diseases and conditions with unmet medical needs, including neurodegenerative diseases, cancer, and autoimmune disorders. Its lead product candidate, pepinemab, is in clinical development for the treatment of Alzheimer’s disease, head and neck, pancreatic and breast cancer. Its lead platform technologies include SEMA4D antibody platform and ActivMAb antibody discovery platform. SEMA4D antibody platform is the application of its knowledge of SEMA4D biology to develop pepinemab for the treatment of various diseases and conditions, including cancer. ActivMAb antibody discovery platform is a human antibody discovery platform based on a method for expressing multipass membrane proteins, as well as large and diverse libraries of high affinity, full-length human monoclonal antibodies on the surface of mammalian pox viruses.
- Revenue in USD (TTM)356.00k
- Net income in USD-17.76m
- Incorporated2001
- Employees37.00
- LocationVaccinex Inc1895 Mount Hope AveROCHESTER 14620-4540United StatesUSA
- Phone+1 (585) 271-2700
- Fax+1 (585) 271-2765
- Websitehttps://www.vaccinex.com/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Yubo International Biotech Ltd | 454.29k | -1.42m | 10.54m | 18.00 | -- | -- | -- | 23.21 | -0.0118 | -0.0118 | 0.0038 | -0.0211 | 0.2462 | 0.5986 | 3.49 | 25,238.33 | -82.33 | -- | -- | -- | 80.30 | -- | -334.36 | -- | 0.1707 | -4,795.69 | -- | -- | 479.86 | -- | 0.8224 | -- | -- | -- |
| GlycoMimetics Inc | 10.00k | -39.11m | 10.63m | 35.00 | -- | 0.5297 | -- | 1,062.70 | -0.6071 | -0.6071 | 0.0002 | 0.3111 | 0.0002 | -- | 0.0685 | 285.71 | -90.71 | -43.60 | -103.87 | -47.82 | -- | -- | -391,132.40 | -2,243.52 | -- | -- | 0.00 | -- | -86.67 | -- | 20.97 | -- | -29.82 | -- |
| Kiora Pharmaceuticals Inc | 16.02m | 2.67m | 10.87m | 12.00 | -- | 0.3285 | 4.03 | 0.6787 | -7.76 | -7.76 | 6.61 | 11.14 | 0.5279 | -- | 7.16 | 1,335,000.00 | 10.54 | -70.52 | 11.20 | -81.86 | -- | -- | 19.98 | -2,040.61 | -- | -- | 0.00 | -- | -- | -- | 3.97 | -- | -- | -- |
| Dominari Holdings Inc | 9.51m | -22.02m | 11.67m | 26.00 | -- | 0.2742 | -- | 1.23 | -3.85 | -3.85 | 1.67 | 6.78 | 0.1629 | -- | 2.60 | 365,730.80 | -37.71 | -26.82 | -39.96 | -27.45 | -- | -- | -231.55 | -3,353.52 | -- | -5.05 | 0.00 | -- | -- | 135.75 | 12.72 | -- | 63.99 | -- |
| Tenax Therapeutics Inc | 0.00 | -12.57m | 12.17m | 5.00 | -- | 0.7876 | -- | -- | -22.35 | -22.35 | 0.00 | 4.53 | 0.00 | -- | -- | 0.00 | -101.95 | -199.16 | -113.79 | -285.64 | -- | -- | -- | -- | -- | -95.94 | 0.0305 | -- | -- | -- | 30.21 | -- | -- | -- |
| Vaccinex Inc | 356.00k | -17.76m | 12.35m | 37.00 | -- | -- | -- | 34.69 | -24.59 | -24.59 | 0.3183 | -1.81 | 0.1306 | -- | 0.6742 | 9,621.62 | -651.39 | -262.29 | -- | -- | -- | -- | -4,987.92 | -4,257.17 | -- | -52.60 | -- | -- | 107.27 | -4.67 | -2.20 | -- | -22.20 | -- |
| Aspira Women's Health Inc | 8.92m | -15.95m | 12.95m | 64.00 | -- | -- | -- | 1.45 | -1.45 | -1.45 | 0.801 | -0.2892 | 1.53 | 15.11 | 5.79 | 139,421.90 | -273.16 | -110.58 | -3,758.30 | -151.88 | 57.84 | 45.23 | -178.80 | -334.08 | 0.5542 | -17,354.00 | -- | -- | 11.85 | 24.56 | 44.15 | -- | -26.65 | -- |
| BioRestorative Therapies Inc | 174.10k | -8.00m | 13.29m | 11.00 | -- | 1.23 | -- | 76.31 | -1.22 | -1.22 | 0.029 | 1.56 | 0.0118 | -- | 6.65 | 15,827.27 | -54.42 | -192.11 | -68.75 | -329.32 | 47.45 | -- | -4,597.79 | -19,116.15 | -- | -- | 0.00 | -- | 21.70 | 5.61 | 43.67 | -- | 67.77 | -- |
| Conduit Pharmaceuticals Inc | 0.00 | -5.17m | 13.34m | 7.00 | -- | -- | -- | -- | -0.0667 | -0.0667 | 0.00 | -0.0738 | 0.00 | -- | -- | 0.00 | -312.39 | -- | -- | -- | -- | -- | -- | -- | -- | -21.32 | -- | -- | -- | -- | 89.05 | -- | -- | -- |
| Sensei Biotherapeutics Inc | 0.00 | -29.67m | 13.47m | 28.00 | -- | 0.2577 | -- | -- | -1.18 | -1.18 | 0.00 | 2.08 | 0.00 | -- | -- | 0.00 | -39.73 | -47.03 | -42.67 | -54.33 | -- | -- | -- | -- | -- | -- | 0.0232 | -- | -- | -- | 29.82 | -- | 42.16 | -- |
| NKGen Biotech Inc | 0.00 | -88.25m | 13.65m | 63.00 | -- | -- | -- | -- | -3.74 | -3.74 | 0.00 | -2.71 | 0.00 | -- | -- | 0.00 | -480.25 | -- | -- | -- | -- | -- | -- | -- | -- | -0.4822 | -- | -- | -100.00 | -- | -210.06 | -- | -- | -- |
| Eom Pharmaceutical Holdings Inc | 0.00 | -4.93m | 14.05m | 3.00 | -- | -- | -- | -- | -0.0435 | -0.0435 | 0.00 | -0.0212 | -- | -- | -- | 0.00 | -- | -126.34 | -- | -171.37 | -- | -- | -- | -- | -- | -- | 7.41 | -- | -- | -- | -254.37 | -- | -- | -- |
| Holder | Shares | % Held |
|---|---|---|
| Point72 Asset Management LPas of 30 Jun 2024 | 116.55k | 6.75% |
| AIGH Capital Management LLCas of 30 Jun 2024 | 108.96k | 6.31% |
| Armistice Capital LLCas of 30 Jun 2024 | 94.00k | 5.44% |
| Tower Research Capital LLCas of 30 Jun 2024 | 1.32k | 0.08% |
| Morgan Stanley & Co. LLCas of 30 Jun 2024 | 1.11k | 0.06% |
| Group One Trading LPas of 30 Jun 2024 | 67.00 | 0.00% |
| Osaic Wealth, Inc. (Investment Management)as of 30 Jun 2024 | 53.00 | 0.00% |
| RBC Dominion Securities, Inc. (Investment Management)as of 30 Jun 2024 | 37.00 | 0.00% |
| Bank of America, NA (Private Banking)as of 30 Jun 2024 | 8.00 | 0.00% |
| Capital Advisors Ltd. LLCas of 30 Jun 2024 | 3.00 | 0.00% |
